RedHill Biopharma (RDHL) Now Covered By Nomura with $18.0 Target; Alkeon Capital Management Has Boosted By $19.40 Million Its Equinix (EQIX) Stake

Among 8 analysts covering RedHill Biopharma (NASDAQ:RDHL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. RedHill Biopharma has $33 highest and $18 lowest target. $24.63’s average target is 297.26% above currents $6.2 stock price. RedHill Biopharma had 14 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by FBR Capital on Friday, February 24 with “Outperform”. Nomura initiated RedHill Biopharma Ltd. (NASDAQ:RDHL) on Tuesday, September 29 with “Buy” rating. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Thursday, June 15 by FBR Capital. Roth Capital maintained the stock with “Buy” rating in Tuesday, November 14 report. As per Saturday, August 22, the company rating was upgraded by Zacks. Northland Capital initiated RedHill Biopharma Ltd. (NASDAQ:RDHL) on Tuesday, September 29 with “Buy” rating. On Monday, July 31 the stock rating was maintained by Roth Capital with “Buy”. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Thursday, June 15 by H.C. Wainwright. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) earned “Buy” rating by TH Capital on Wednesday, July 29. TheStreet downgraded RedHill Biopharma Ltd. (NASDAQ:RDHL) on Tuesday, August 25 to “Hold” rating.

Alkeon Capital Management Llc increased Equinix Inc (EQIX) stake by 10.96% reported in 2017Q3 SEC filing. Alkeon Capital Management Llc acquired 43,500 shares as Equinix Inc (EQIX)’s stock rose 14.02%. The Alkeon Capital Management Llc holds 440,342 shares with $196.52M value, up from 396,842 last quarter. Equinix Inc now has $34.55 billion valuation. The stock increased 0.55% or $2.42 during the last trading session, reaching $441.59. About 1.23M shares traded or 152.60% up from the average. Equinix, Inc. (NASDAQ:EQIX) has risen 24.40% since January 28, 2017 and is uptrending. It has outperformed by 7.70% the S&P500.

Among 23 analysts covering Equinix (NASDAQ:EQIX), 21 have Buy rating, 0 Sell and 2 Hold. Therefore 91% are positive. Equinix had 60 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Equinix, Inc. (NASDAQ:REIT) earned “Buy” rating by Deutsche Bank on Tuesday, October 24. The rating was maintained by SunTrust with “Buy” on Thursday, October 12. SunTrust maintained Equinix, Inc. (NASDAQ:REIT) on Wednesday, December 6 with “Buy” rating. RBC Capital Markets maintained Equinix, Inc. (NASDAQ:REIT) on Tuesday, July 28 with “Outperform” rating. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, August 2. On Thursday, November 2 the stock rating was maintained by Nomura with “Buy”. The firm has “Buy” rating given on Tuesday, November 24 by SunTrust. The firm has “Buy” rating given on Tuesday, November 24 by Suntrust Robinson. The firm has “Buy” rating given on Friday, July 7 by RBC Capital Markets. The firm has “Buy” rating by Canaccord Genuity given on Thursday, May 11.

Alkeon Capital Management Llc decreased Target Corp (Call) (NYSE:TGT) stake by 400,000 shares to 1.60 million valued at $94.42 million in 2017Q3. It also reduced Cintas Corp (NASDAQ:CTAS) stake by 438,700 shares and now owns 367,210 shares. Broadcom Ltd was reduced too.

Since August 7, 2017, it had 0 insider purchases, and 13 sales for $18.95 million activity. $1.98M worth of Equinix, Inc. (NASDAQ:REIT) was sold by VAN CAMP PETER. $1.87 million worth of Equinix, Inc. (NASDAQ:REIT) was sold by TAYLOR KEITH D. Meyers Charles J also sold $501,183 worth of Equinix, Inc. (NASDAQ:REIT) on Friday, September 1. 4,942 shares were sold by Schwartz Eric, worth $2.19 million on Tuesday, January 16. PAISLEY CHRISTOPHER B sold $222,980 worth of Equinix, Inc. (NASDAQ:REIT) on Monday, August 7. Shares for $2.71M were sold by STROHMEYER KARL on Tuesday, January 16. Another trade for 10,706 shares valued at $4.74 million was made by Smith Stephen M on Tuesday, January 16.

Investors sentiment decreased to 1.4 in 2017 Q3. Its down 0.06, from 1.46 in 2017Q2. It turned negative, as 24 investors sold EQIX shares while 144 reduced holdings. 59 funds opened positions while 177 raised stakes. 73.29 million shares or 0.60% less from 73.73 million shares in 2017Q2 were reported. Selkirk Mngmt Ltd Liability holds 43,900 shares. Manufacturers Life Ins The owns 159,665 shares. Highland Capital Mgmt Limited Liability reported 0.03% in Equinix, Inc. (NASDAQ:REIT). Pggm Invests holds 0.02% of its portfolio in Equinix, Inc. (NASDAQ:REIT) for 9,472 shares. Tcw Group Inc accumulated 1.38% or 390,206 shares. M&T Fincl Bank accumulated 6,129 shares. Ifc Inc Fl holds 0.04% or 1,171 shares. British Columbia accumulated 55,172 shares or 0.19% of the stock. Northpointe Capital Limited Com owns 6,905 shares. Amica Pension Fund Board Of Trustees reported 2,767 shares. Shine Inv Advisory holds 44 shares. Keybank National Association Oh has 1,394 shares. State Treasurer State Of Michigan stated it has 23,638 shares or 0.09% of all its holdings. Kayne Anderson Rudnick Investment Lc reported 0.02% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys has invested 0.04% in Equinix, Inc. (NASDAQ:REIT).

Analysts await RedHill Biopharma Ltd. (NASDAQ:RDHL) to report earnings on February, 22. They expect $-0.65 EPS, up 7.14% or $0.05 from last year’s $-0.7 per share. After $-0.90 actual EPS reported by RedHill Biopharma Ltd. for the previous quarter, Wall Street now forecasts -27.78% EPS growth.

The stock increased 11.31% or $0.63 during the last trading session, reaching $6.2. About 777,093 shares traded or 304.06% up from the average. RedHill Biopharma Ltd. (NASDAQ:RDHL) has declined 9.09% since January 28, 2017 and is downtrending. It has underperformed by 25.79% the S&P500.